As showed in Fig. 5C and D, 4T1 tumor cell transendothelial migration could be enhanced by FBS or VEGF and Oridonin decreased VEGF-induced migration more effectively than FBS-induced trans-HUVEC migration, with an IC50 of less than 1 μM. Here, VEGFA is linked to neoplasm.